Product Name

  • Name

    Myristicin

  • EINECS 210-146-9
  • CAS No. 607-91-0
  • Density 1.137 g/cm3
  • Solubility
  • Melting Point <-20oC
  • Formula C11H12O3
  • Boiling Point 276.5 °C at 760 mmHg
  • Molecular Weight 192.214
  • Flash Point 89.8 °C
  • Transport Information
  • Appearance
  • Safety 61
  • Risk Codes 52/53
  • Molecular Structure Molecular Structure of 607-91-0 (Myristicin)
  • Hazard Symbols R52/53:;
  • Synonyms 1,3-Benzodioxole,4-methoxy-6-(2-propenyl)- (9CI);Benzene,5-allyl-1-methoxy-2,3-(methylenedioxy)- (7CI,8CI);Myristicin (6CI);5-Allyl-1-methoxy-2,3-(methylenedioxy)benzene;6-Allyl-4-methoxy-1,3-benzodioxole;Myristicine;
  • PSA 27.69000
  • LogP 2.15240

Synthetic route

diiodomethane
75-11-6

diiodomethane

5-Hydroxyeugenol
4055-72-5

5-Hydroxyeugenol

myristicin
607-91-0

myristicin

Conditions
ConditionsYield
With potassium carbonate
5-Hydroxyeugenol
4055-72-5

5-Hydroxyeugenol

1,2-dibromomethane
74-95-3

1,2-dibromomethane

myristicin
607-91-0

myristicin

Conditions
ConditionsYield
With potassium carbonate
With potassium carbonate In acetone for 20h; Reflux;
diiodomethane
75-11-6

diiodomethane

5-Hydroxyeugenol
4055-72-5

5-Hydroxyeugenol

acetone
67-64-1

acetone

K2CO3

K2CO3

myristicin
607-91-0

myristicin

Conditions
ConditionsYield
unter Wasserstoff;
4-allylguaiacol
97-53-0

4-allylguaiacol

myristicin
607-91-0

myristicin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
2: alkaline aqueous H2O2
3: potassium carbonate
View Scheme
Multi-step reaction with 3 steps
2: alkaline aqueous H2O2
3: potassium carbonate
View Scheme
Multi-step reaction with 3 steps
1: hexan-1-amine / 6 h / Heating
2: dihydrogen peroxide; pyridine; sodium hydroxide / water / 1.5 h / 20 °C
3: potassium carbonate / acetone / 20 h / Reflux
View Scheme
5-allyl-2-hydroxy-3-methoxybenzaldehyde
22934-51-6

5-allyl-2-hydroxy-3-methoxybenzaldehyde

myristicin
607-91-0

myristicin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: alkaline aqueous H2O2
2: potassium carbonate
View Scheme
Multi-step reaction with 2 steps
1: alkaline aqueous H2O2
2: potassium carbonate
View Scheme
Multi-step reaction with 2 steps
1: dihydrogen peroxide; pyridine; sodium hydroxide / water / 1.5 h / 20 °C
2: potassium carbonate / acetone / 20 h / Reflux
View Scheme
2-allyloxy-3-methoxy-phenol
71186-63-5

2-allyloxy-3-methoxy-phenol

myristicin
607-91-0

myristicin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 170 - 200 °C / unter Wasserstoff
2: potassium carbonate
View Scheme
Multi-step reaction with 2 steps
1: 170 - 200 °C / unter Wasserstoff
2: potassium carbonate
View Scheme
2-(allyloxy)-6-methoxyphenol
51066-05-8

2-(allyloxy)-6-methoxyphenol

myristicin
607-91-0

myristicin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 170 - 200 °C / unter Wasserstoff
2: potassium carbonate
View Scheme
Multi-step reaction with 2 steps
1: 170 - 200 °C / unter Wasserstoff
2: potassium carbonate
View Scheme
myristicin
607-91-0

myristicin

2-bromo-1-(3-methoxy-4,5-methylenedioxyphenyl)propane
157426-98-7

2-bromo-1-(3-methoxy-4,5-methylenedioxyphenyl)propane

Conditions
ConditionsYield
With hydrogen bromide at 20℃;99.22%
myristicin
607-91-0

myristicin

4-methoxy-6-propyl-benzo[1,3]dioxole
52811-28-6

4-methoxy-6-propyl-benzo[1,3]dioxole

Conditions
ConditionsYield
With 1% Pd on activated carbon; hydrogen In water at 20℃; under 760.051 Torr; for 12h; Reagent/catalyst; Green chemistry; chemoselective reaction;99%
With ethanol; palladium Hydrogenation;
With hydrogen In methanol at 20℃; under 15001.5 Torr; for 2h; Autoclave;
myristicin
607-91-0

myristicin

ethyl 2-chloro-2-(hydroxyimino)acetate
14337-43-0

ethyl 2-chloro-2-(hydroxyimino)acetate

ethyl 5-(3-methoxy-4,5-methylenedioxybenzyl)-4,5-dihydroisoxazole-3-carboxylate
924859-11-0

ethyl 5-(3-methoxy-4,5-methylenedioxybenzyl)-4,5-dihydroisoxazole-3-carboxylate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 24h;69%
myristicin
607-91-0

myristicin

N-hydroxy-4-methoxy-benzenecarboximidoyl chloride
38435-51-7

N-hydroxy-4-methoxy-benzenecarboximidoyl chloride

5-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3-(4-methoxyphen-yl)-4,5-dihydroisoxazole
936080-17-0

5-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3-(4-methoxyphen-yl)-4,5-dihydroisoxazole

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 17h;68%
With triethylamine In dichloromethane for 24h;67%
myristicin
607-91-0

myristicin

4-nitrobenzonitrile
619-72-7

4-nitrobenzonitrile

A

4-methoxy-7-methyl-9-(4-nitrophenyl)-6,7-dihydro-2H-[1,3]dioxolo[4,5-h]isoquinoline

4-methoxy-7-methyl-9-(4-nitrophenyl)-6,7-dihydro-2H-[1,3]dioxolo[4,5-h]isoquinoline

B

4-methoxy-7-methyl-5-(4-nitrophenyl)-7,8-dihydro-2H-[1,3]dioxolo[4,5-g]isoquinoline

4-methoxy-7-methyl-5-(4-nitrophenyl)-7,8-dihydro-2H-[1,3]dioxolo[4,5-g]isoquinoline

Conditions
ConditionsYield
With trifluorormethanesulfonic acid In dichloromethane for 0.25h; Reflux;A 20%
B 55%
myristicin
607-91-0

myristicin

4-bromobenzenecarbonitrile
623-00-7

4-bromobenzenecarbonitrile

A

9-(4-bromophenyl)-4-methoxy-7-methyl-6,7-dihydro-2H-[1,3]dioxolo[4,5-h]isoquinoline

9-(4-bromophenyl)-4-methoxy-7-methyl-6,7-dihydro-2H-[1,3]dioxolo[4,5-h]isoquinoline

B

5-(4-bromophenyl)-4-methoxy-7-methyl-7,8-dihydro-2H-[1,3]dioxolo[4,5-g]isoquinoline

5-(4-bromophenyl)-4-methoxy-7-methyl-7,8-dihydro-2H-[1,3]dioxolo[4,5-g]isoquinoline

Conditions
ConditionsYield
With trifluorormethanesulfonic acid In dichloromethane for 0.25h; Reflux;A 10%
B 54%
myristicin
607-91-0

myristicin

3-(3-methoxy-4,5-methylenedioxy-phenyl)-2-propen-1-ol
76897-04-6

3-(3-methoxy-4,5-methylenedioxy-phenyl)-2-propen-1-ol

Conditions
ConditionsYield
With selenium(IV) oxide In 1,4-dioxane; water at 85℃; for 0.0833333h;24%
myristicin
607-91-0

myristicin

Conditions
ConditionsYield
With ammonium hydroxide; Spirulina platensis phenylalanine ammonia-lyase In acetone at 37℃; for 1h; pH=8; Reagent/catalyst; Enzymatic reaction;15.3%
methyl thiocyanate
556-64-9

methyl thiocyanate

myristicin
607-91-0

myristicin

A

4-methoxy-7-methyl-5-methylsulfanyl-7,8-dihydro-2H-[1,3]dioxolo[4,5-g]isoquinoline

4-methoxy-7-methyl-5-methylsulfanyl-7,8-dihydro-2H-[1,3]dioxolo[4,5-g]isoquinoline

B

4-mMethoxy-7-methyl-9-methylsulfanyl-6,7-dihydro-2H-[1,3]dioxolo[4,5-h]isoquinoline

4-mMethoxy-7-methyl-9-methylsulfanyl-6,7-dihydro-2H-[1,3]dioxolo[4,5-h]isoquinoline

Conditions
ConditionsYield
With trifluorormethanesulfonic acid In dichloromethane for 0.25h; Reflux;A 10%
B 2%
methyl magnesium iodide
917-64-6

methyl magnesium iodide

myristicin
607-91-0

myristicin

2-ethoxy-4-allyl-6-methoxy-phenol

2-ethoxy-4-allyl-6-methoxy-phenol

Conditions
ConditionsYield
With benzene
myristicin
607-91-0

myristicin

Nitrosobenzene
586-96-9

Nitrosobenzene

3-(7-methoxy-benzo[1,3]dioxol-5-yl)-acrylaldehyde-(N-phenyl oxime )

3-(7-methoxy-benzo[1,3]dioxol-5-yl)-acrylaldehyde-(N-phenyl oxime )

Conditions
ConditionsYield
With diethyl ether im Dunkeln;
myristicin
607-91-0

myristicin

trans-isomyristicin
18312-21-5

trans-isomyristicin

Conditions
ConditionsYield
With potassium hydroxide
With sodium under 10 Torr; beim Destillieren;
myristicin
607-91-0

myristicin

5-methoxy-3,4-methylenedioxybenzoic acid
526-34-1

5-methoxy-3,4-methylenedioxybenzoic acid

Conditions
ConditionsYield
With potassium permanganate; water
Multi-step reaction with 3 steps
1.1: tetrabutylammomium bromide; potassium hydroxide / 0.67 h / 100 °C
2.1: pyridine; ozone / methanol; chloroform / -15 - 0 °C
3.1: ammonium hydroxide; iodine / tetrahydrofuran; water / 16 h / 20 °C
3.2: 4 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1: tetrabutylammomium bromide; potassium hydroxide / 0.67 h / 100 °C
2: pyridine; ozone / methanol; chloroform / -15 - 0 °C
3: urea hydrogen peroxide adduct; sodium hydroxide / methanol; water / Reflux
View Scheme
Multi-step reaction with 3 steps
1: tetrabutylammomium bromide; potassium hydroxide / 0.67 h / 100 °C / Neat (no solvent)
2: pyridine; ozone / methanol; chloroform / -15 °C
3: urea hydrogen peroxide adduct; sodium hydroxide / methanol; water / 1.5 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1: potassium hydroxide / 0.67 h / 100 °C
2: ozone; pyridine / methanol; chloroform / -15 °C
3: urea hydrogen peroxide adduct / methanol / 1.5 h / Reflux
View Scheme
myristicin
607-91-0

myristicin

A

5-methoxy-3,4-methylenedioxybenzoic acid
526-34-1

5-methoxy-3,4-methylenedioxybenzoic acid

B

(7-methoxy-benzo[1,3]dioxol-5-yl)-acetic acid
4408-61-1

(7-methoxy-benzo[1,3]dioxol-5-yl)-acetic acid

Conditions
ConditionsYield
With potassium permanganate; ethanol; sodium sulfate Reagens 4: Magnesiumcarbonat;
myristicin
607-91-0

myristicin

2′,3′-dihydroxymyristicin
54306-09-1, 140385-38-2

2′,3′-dihydroxymyristicin

Conditions
ConditionsYield
With potassium hydroxide; potassium permanganate
myristicin
607-91-0

myristicin

1-iodo-3-(7-methoxy-benzo[1,3]dioxol-5-yl)-propan-2-ol

1-iodo-3-(7-methoxy-benzo[1,3]dioxol-5-yl)-propan-2-ol

Conditions
ConditionsYield
With ethanol; iodine; mercury(II) oxide
myristicin
607-91-0

myristicin

(7-methoxy-benzo[1,3]dioxol-5-yl)-acetaldehyde oxime

(7-methoxy-benzo[1,3]dioxol-5-yl)-acetaldehyde oxime

Conditions
ConditionsYield
With palladium on activated charcoal; Lindlar's catalyst; ozone; ethyl acetate at -12℃; Erwaermen des Reaktionsprodukts mit Methanol, Hydroxylamin-hydrochlorid und wss. Kalilauge;
myristicin
607-91-0

myristicin

4,6-dibromo-5-(2,3-dibromo-propyl)-7-methoxy-benzo[1,3]dioxole
52811-29-7

4,6-dibromo-5-(2,3-dibromo-propyl)-7-methoxy-benzo[1,3]dioxole

Conditions
ConditionsYield
With bromine; acetic acid at 0℃;
myristicin
607-91-0

myristicin

myristicin nitrosite

myristicin nitrosite

Conditions
ConditionsYield
With cis-nitrous acid
myristicin
607-91-0

myristicin

N-methyl-N-phenylformamide
93-61-8

N-methyl-N-phenylformamide

4-Methoxy-7,8-dihydronaphtho<2,3-d>-1,3-dioxol-6-carbaldehyd

4-Methoxy-7,8-dihydronaphtho<2,3-d>-1,3-dioxol-6-carbaldehyd

Conditions
ConditionsYield
With trichlorophosphate 1) chlorobenzene, 2 h, 0 deg C, 2) chlorobenzene, 80 h, r.t.; Yield given. Multistep reaction;
myristicin
607-91-0

myristicin

A

trans-isomyristicin
18312-21-5

trans-isomyristicin

B

(Z)-4-methoxy-6-(prop-2-enyl)benzo[d][1,3]dioxole

(Z)-4-methoxy-6-(prop-2-enyl)benzo[d][1,3]dioxole

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 15h; Heating; Yield given. Yields of byproduct given;
With potassium hydroxide In ethanol for 15h; Heating; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
myristicin
607-91-0

myristicin

ethanol
64-17-5

ethanol

iodine
7553-56-2

iodine

yellow mercury oxide

yellow mercury oxide

13-iodo-12-oxy-3-methoxy-4.5-methylenedioxy-1-propyl-benzene

13-iodo-12-oxy-3-methoxy-4.5-methylenedioxy-1-propyl-benzene

myristicin
607-91-0

myristicin

mercury(II) diacetate
1600-27-7

mercury(II) diacetate

water
7732-18-5

water

benzene
71-43-2

benzene

1-hydroxymethyl-2-<7-methoxy-benzo<1,3>dioxol-5-yl>-ethylmercury acetate

1-hydroxymethyl-2-<7-methoxy-benzo<1,3>dioxol-5-yl>-ethylmercury acetate

myristicin
607-91-0

myristicin

diethyl ether
60-29-7

diethyl ether

Nitrosobenzene
586-96-9

Nitrosobenzene

3-methoxy-4.5-methylenedioxy-cinnamaldoxime-N-phenyl ether

3-methoxy-4.5-methylenedioxy-cinnamaldoxime-N-phenyl ether

myristicin
607-91-0

myristicin

bromine
7726-95-6

bromine

acetic acid
64-19-7

acetic acid

bz-dibromo-myristicin dibromide

bz-dibromo-myristicin dibromide

Conditions
ConditionsYield
at 0℃;
myristicin
607-91-0

myristicin

alcoholic KOH-solution

alcoholic KOH-solution

isomyristicin

isomyristicin

Myristicin Specification

The Myristicin is an organic compound with the formula C11H12O3. The IUPAC name of this chemical is 4-methoxy-6-prop-2-enyl-1,3-benzodioxole. With the CAS registry number 607-91-0, it is also named as 6-Allyl-4-methoxy-1,3-benzodioxole. The product's categories are Miscellaneous Natural Products; Aromatic Phenols. Besides, it should be stored in a closed cool and dry place.

It speculated myristicin could be metabolized to MMDA, a psychoactive drug related to MDA, in the liver. This speculation has never been confirmed and studies with the closely related compounds asarone and safrole demonstrated the proposed transamination reactions did not take place in humans. There are also data to suggest myristicin can alter the toxicity and/or metabolic pathway of some compounds and it is a weak MAOI.

Physical properties about Myristicin are: (1)ACD/LogP: 3.26; (2)ACD/LogD (pH 5.5): 3.26; (3)ACD/LogD (pH 7.4): 3.26; (4)ACD/BCF (pH 5.5): 178.18; (5)ACD/BCF (pH 7.4): 178.18; (6)ACD/KOC (pH 5.5): 1421.57; (7)ACD/KOC (pH 7.4): 1421.57; (8)#H bond acceptors: 3; (9)#Freely Rotating Bonds: 3; (10)Polar Surface Area: 27.69 Å2; (11)Index of Refraction: 1.539; (12)Molar Refractivity: 53 cm3; (13)Molar Volume: 169 cm3; (14)Polarizability: 21.01×10-24cm3; (15)Surface Tension: 39.8 dyne/cm; (16)Density: 1.137 g/cm3; (17)Flash Point: 89.8 °C Enthalpy of; (18)Vaporization: 49.43 kJ/mol; (19)Boiling Point: 276.5 °C at 760 mmHg; (20)Vapour Pressure: 0.00805 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: O1c2cc(cc(OC)c2OC1)C\C=C
(2)InChI: InChI=1/C11H12O3/c1-3-4-8-5-9(12-2)11-10(6-8)13-7-14-11/h3,5-6H,1,4,7H2,2H3
(3)InChIKey: BNWJOHGLIBDBOB-UHFFFAOYAE
(4)Std. InChI: InChI=1S/C11H12O3/c1-3-4-8-5-9(12-2)11-10(6-8)13-7-14-11/h3,5-6H,1,4,7H2,2H3
(5)Std. InChIKey: BNWJOHGLIBDBOB-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LDLo oral 400mg/kg (400mg/kg) BEHAVIORAL: GENERAL ANESTHETIC

LIVER: FATTY LIVER DEGERATION
American Journal of Pharmacy Vol. 80, Pg. 563, 1909.
guinea pig LDLo subcutaneous 2gm/kg (2000mg/kg) BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS

LIVER: OTHER CHANGES
American Journal of Pharmacy Vol. 80, Pg. 563, 1909.
human TDLo oral 5700ug/kg (5.7mg/kg) BEHAVIORAL: WAKEFULNESS

BEHAVIORAL: EUPHORIA

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

Journal of Neuropsychiatry. Vol. 2, Pg. 205, 1961.

rabbit LDLo subcutaneous 900mg/kg (900mg/kg) BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS

LIVER: OTHER CHANGES
American Journal of Pharmacy Vol. 80, Pg. 563, 1909.
rat LD50 oral 4260mg/kg (4260mg/kg)   Journal of Agricultural and Food Chemistry. Vol. 30, Pg. 563, 1982.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View